{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T21:11:01Z","timestamp":1794777061908,"version":"4.9.1"},"reference-count":58,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"unspecified","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"crossref","award":["15669"],"award-info":[{"award-number":["15669"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,11,20]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Total mesorectal excision (TME) is highly effective for early-stage rectal cancer, but is associated with considerable morbidity, which can substantially impair the quality of life (QoL) of patients. For very early tumours (low-risk cT1), local excision (LE) offers the possibility of organ preservation (OP) with reduced morbidity; however, its application is limited to a selected group. For early tumours where upfront LE is not feasible, primary OP with (chemo)radiotherapy as an alternative to TME surgery has been evaluated in the STARTREC phase II\/III studies, which reported promising 1-year OP rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The STARTREC-3 trial aims to increase the 2-year OP rate from 60% to 80% in early rectal cancer (cT1\u20133abN0) and from 30% to 60% in early-intermediate rectal cancer (cT1\u20133abN1, \u22643 mesorectal nodes measuring \u22648\u2009mm) by intensifying neoadjuvant treatment in different study arms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>STARTREC-3 is embedded in the STARTREC master trial protocol, which uses an adaptive platform study design allowing early termination of inferior treatment arms and the addition of novel arms. The multicentre STARTREC-3 trial investigates three parallel, non-comparative treatment strategies for patients with early and early-intermediate rectal adenocarcinoma who prefer OP over primary TME surgery. All arms start with 5\u00d75\u2009Gy radiotherapy, followed by: an endoluminal boost via contact X-ray brachytherapy (arm 1), an external beam radiotherapy (EBRT) boost by MR-guided EBRT (arm 2) or three cycles of capecitabine oxaliplatin systemic treatment chemotherapy (arm 3). Treatment allocation is predefined and centre-dependent. Response evaluations (MRI and endoscopy) are planned at 14\u201316 weeks and 26 weeks after onset of radiotherapy. The primary endpoint is the proportion of patients with successful OP at 24 months from onset of therapy. Secondary endpoints include toxicity, QoL, functional and oncological outcomes. Data will be analysed separately for early (cN0) and early-intermediate (cN1) disease. The total planned sample size is 210 patients across the three arms. Interim analyses will be performed for each study arm to determine early failures and discontinue ineffective arms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The trial was approved by the medical ethics committee NedMec of the Netherlands and is registered in the EU Clinical Trials Information System (CTIS). The results will be published in an international peer-reviewed journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>CTIS EU 2024-514620-17-00<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-111711","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:20:47Z","timestamp":1765974047000},"page":"e111711","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Can we Save the rectum by watchful waiting or transanal microsurgery following shorT-course radiotherapy and Additional local oR systemic Treatment for early-stage REctal Cancer? STARTREC-3 protocol for a non-randomised, multicentre, phase II platform study"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8788-1810","authenticated-orcid":false,"given":"Suzanne E N","family":"de Vries","sequence":"first","affiliation":[{"name":"Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands"},{"name":"Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice M","family":"Couwenberg","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrie A M","family":"Marijnen","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Netherlands Cancer Institute, Amsterdam, The Netherlands"},{"name":"Department of Radiotherapy, LUMC, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geerard L","family":"Beets","sequence":"additional","affiliation":[{"name":"Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands"},{"name":"Department of Surgery, Maastricht University Medical Centre+, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus WA","family":"Burger","sequence":"additional","affiliation":[{"name":"Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Chalabi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem","family":"de Groot","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Isala Hospital, Zwolle, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Intven","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike M","family":"Peulen","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Catharina Hospital, Eindhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine M L","family":"Roodhart","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes H W","family":"de Wilt","sequence":"additional","affiliation":[{"name":"Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brechtje A","family":"Grotenhuis","sequence":"additional","affiliation":[{"name":"Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"2026010703473043000_15.12.e111711.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08268-5"},{"key":"2026010703473043000_15.12.e111711.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38153.491887.7C"},{"key":"2026010703473043000_15.12.e111711.3","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ejso.2021.11.132","article-title":"Changes in rectal cancer treatment after the introduction of a national screening program; Increasing use of less invasive strategies within a national cohort","volume":"48","author":"Giesen","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"2026010703473043000_15.12.e111711.4","first-page":"37","article-title":"Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon","volume":"19","author":"Gollins","year":"2017","journal-title":"Rectum and Anus"},{"key":"2026010703473043000_15.12.e111711.5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/01.sla.0000183355.94322.db","article-title":"T1 adenocarcinoma of the rectum: transanal excision or radical surgery?","volume":"242","author":"Bentrem","year":"2005","journal-title":"Ann Surg"},{"key":"2026010703473043000_15.12.e111711.6","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000257358.56863.ce"},{"key":"2026010703473043000_15.12.e111711.7","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-005-0044-6"},{"key":"2026010703473043000_15.12.e111711.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010580"},{"key":"2026010703473043000_15.12.e111711.9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7425.1196"},{"key":"2026010703473043000_15.12.e111711.10","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000171299.43954.ce"},{"key":"2026010703473043000_15.12.e111711.11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.3062"},{"key":"2026010703473043000_15.12.e111711.12","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200308000-00008"},{"key":"2026010703473043000_15.12.e111711.13","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-004-0942-z"},{"key":"2026010703473043000_15.12.e111711.14","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200102000-00001"},{"key":"2026010703473043000_15.12.e111711.15","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/bjs.6376","article-title":"Clinical and non-clinical factors influencing postoperative health-related quality of life in patients with colorectal cancer","volume":"95","author":"Wilson","year":"2008","journal-title":"Br J Surg"},{"key":"2026010703473043000_15.12.e111711.16","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ejso.2021.11.002","article-title":"Treatment of clinical T1 rectal cancer in the Netherlands; a population-based overview of clinical practice","volume":"48","author":"Verseveld","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"2026010703473043000_15.12.e111711.17","doi-asserted-by":"publisher","DOI":"10.1055\/a-1748-8573"},{"key":"2026010703473043000_15.12.e111711.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040694"},{"key":"2026010703473043000_15.12.e111711.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60484-0"},{"key":"2026010703473043000_15.12.e111711.20","article-title":"Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma","volume":"2007","author":"Wong","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2026010703473043000_15.12.e111711.21","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199904000-00007"},{"key":"2026010703473043000_15.12.e111711.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.12.012"},{"key":"2026010703473043000_15.12.e111711.23","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000141194.27992.32"},{"key":"2026010703473043000_15.12.e111711.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31078-X"},{"key":"2026010703473043000_15.12.e111711.25","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70172-8"},{"key":"2026010703473043000_15.12.e111711.26","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00215-6"},{"key":"2026010703473043000_15.12.e111711.27","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/bjs.9809","article-title":"Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study)","volume":"102","author":"Verseveld","year":"2015","journal-title":"Br J Surg"},{"key":"2026010703473043000_15.12.e111711.28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(17)31056-5","article-title":"Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial","volume":"390","author":"Rullier","year":"2017","journal-title":"Lancet"},{"key":"2026010703473043000_15.12.e111711.29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S2468-1253(20)30333-2","article-title":"Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study","volume":"6","author":"Bach","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026010703473043000_15.12.e111711.30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019474","article-title":"Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study","volume":"7","author":"Rombouts","year":"2017","journal-title":"BMJ Open"},{"key":"2026010703473043000_15.12.e111711.31","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/j.clon.2022.12.006","article-title":"STAR-TREC: An International Three-arm Multicentre, Partially Randomised Controlled Trial Incorporating an External Pilot","volume":"35","author":"Bach","year":"2023","journal-title":"Clin Oncol"},{"key":"2026010703473043000_15.12.e111711.32","doi-asserted-by":"crossref","unstructured":"CAM Marijnen D-M , Homer V , Gates S , eds. STAR-TREC (NCT02945566): a randomised phase II\/III trial of CRT versus 5x5 Gy SCRT for organ preservation in early\/intermediate risk rectal cancer. Vienna, Austria: European Society for Radiotherapy and Oncology, 2025.","DOI":"10.1016\/S0167-8140(25)00493-1"},{"key":"2026010703473043000_15.12.e111711.33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.clon.2007.07.010","article-title":"The Radiobiology of Papillon-type Treatments","volume":"19","author":"Dale","year":"2007","journal-title":"Clin Oncol"},{"key":"2026010703473043000_15.12.e111711.34","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170175","article-title":"Dose escalation using contact X-ray brachytherapy (Papillon) for rectal cancer: does it improve the chance of organ preservation?","volume":"90","author":"Sun Myint","year":"2017","journal-title":"Br J Radiol"},{"key":"2026010703473043000_15.12.e111711.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.10.022"},{"key":"2026010703473043000_15.12.e111711.36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2468-1253(22)00392-2","article-title":"Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial","volume":"8","author":"Gerard","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026010703473043000_15.12.e111711.37","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.annonc.2024.10.827","article-title":"A phase III randomised trial on the addition of a contact X-ray brachytherapy boost to standard neoadjuvant chemo-radiotherapy for organ preservation in early rectal adenocarcinoma: 5 year results of the OPERA trial","volume":"36","author":"Baron","year":"2025","journal-title":"Ann Oncol"},{"key":"2026010703473043000_15.12.e111711.38","first-page":"153","article-title":"Online MR guided dose escalated radiotherapy for organ preservation in distal rectal cancer","volume":"37","author":"Boeke","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"2026010703473043000_15.12.e111711.39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.radonc.2021.09.002","article-title":"A novel approach for radiotherapy dose escalation in rectal cancer using online MR-guidance and rectal ultrasound gel filling \u2013 Rationale and first in human","volume":"164","author":"Gani","year":"2021","journal-title":"Radiother Oncol"},{"key":"2026010703473043000_15.12.e111711.40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049119","article-title":"A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial","volume":"12","author":"Hudson","year":"2022","journal-title":"BMJ Open"},{"key":"2026010703473043000_15.12.e111711.41","unstructured":"Randomized trial of standard dose versus high dose of radiotherapy in rectal preservation with chemo-radiotherapy to patients with early low and mid rectal cancer: the watchful waiting 3 trial (WW3). 2019."},{"key":"2026010703473043000_15.12.e111711.42","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065010","article-title":"Towards Response ADAptive Radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial","volume":"13","author":"Verweij","year":"2023","journal-title":"BMJ Open"},{"key":"2026010703473043000_15.12.e111711.43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276599","article-title":"Total neoadjuvant therapy versus standard therapy in locally advanced rectal cancer: A systematic review and meta-analysis of 15 trials","volume":"17","author":"Zhang","year":"2022","journal-title":"PLoS ONE"},{"key":"2026010703473043000_15.12.e111711.44","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30555-6"},{"key":"2026010703473043000_15.12.e111711.45","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00079-6"},{"key":"2026010703473043000_15.12.e111711.46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2340\/1651-226X.2025.41057","article-title":"Organ preservation, for rectal cancer: general overview of the latest data from phase III randomized trials","volume":"64","author":"Ben Dhia","year":"2025","journal-title":"Acta Oncol"},{"key":"2026010703473043000_15.12.e111711.47","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00032"},{"key":"2026010703473043000_15.12.e111711.48","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/JCO.23.01208","article-title":"Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial","volume":"42","author":"Verheij","year":"2024","journal-title":"J Clin Oncol"},{"key":"2026010703473043000_15.12.e111711.49","first-page":"104","article-title":"Mesorectal radiotherapy for early stage rectal cancer: A novel target volume","volume":"21","author":"Peters","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"2026010703473043000_15.12.e111711.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2022.12.003"},{"key":"2026010703473043000_15.12.e111711.51","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1200\/JCO.23.01369","article-title":"From Clinical Trials to Practice: Anticipating and Overcoming Challenges in Implementing Watch-and-Wait for Rectal Cancer","volume":"42","author":"Loria","year":"2024","journal-title":"J Clin Oncol"},{"key":"2026010703473043000_15.12.e111711.52","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1200\/JCO.2022.40.16_suppl.3502","article-title":"STAR-TREC phase II: Can we save the rectum by watchful waiting or transanal surgery following (chemo)radiotherapy versus total mesorectal excision for early rectal cancer?","volume":"40","author":"Bach","year":"2022","journal-title":"JCO"},{"key":"2026010703473043000_15.12.e111711.53","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.5506"},{"key":"2026010703473043000_15.12.e111711.54","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.9597"},{"key":"2026010703473043000_15.12.e111711.55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.radonc.2022.04.013","article-title":"Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial","volume":"171","author":"Dijkstra","year":"2022","journal-title":"Radiother Oncol"},{"key":"2026010703473043000_15.12.e111711.56","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102771","article-title":"Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)","volume":"75","author":"Glimelius","year":"2024","journal-title":"EClinicalMedicine"},{"key":"2026010703473043000_15.12.e111711.57","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.ejso.2020.04.014","article-title":"Importance of patient reported and clinical outcomes for patients with locally advanced rectal cancer and their treating physicians. Do clinicians know what patients want?","volume":"46","author":"van der Valk","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"2026010703473043000_15.12.e111711.58","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00318","article-title":"Organ Preservation in Rectal Cancer: The Patients\u2019 Perspective","volume":"9","author":"Gani","year":"2019","journal-title":"Front Oncol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-111711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T11:49:56Z","timestamp":1767786596000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-111711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":58,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,17]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/bmjopen-2025-111711"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-111711","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2025-111711.supp4","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2025-111711.supp1","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2025-111711.supp2","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2025-111711.supp3","asserted-by":"subject"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}